IN8bio Signs Multiple Material Agreements

IN8bio announced a private financing structure comprising a Securities Purchase Agreement, a Registration Rights Agreement, and the issuance of pre-funded warrants. The initial closing, expected around Dec 22, 2025, will raise about $20.1 million through common stock and pre-funded warrants, with a potential second closing of roughly $20.1 million upon INB-619 milestone achievement and a price threshold or waiver. The company granted investors participation rights in future equity financings and may reduce second-closing commitments based on specified collaboration proceeds. Registration rights will enable resale of the securities, while pre-funded warrants offer immediate exercisability with ownership caps.Agreement 1: IN8bio Signs Securities Purchase Agreement With InvestorsAgreement type: Securities Purchase Agreement for private placement of common stock and pre-funded warrantsCounterparty: InvestorsSigned / Effective: Dec 18 2025 / sameDuration / Termination: Through Dec 31 2026 for Second Closing trigger windowReason: Raise capital for pipeline and operationsAgreement 2: IN8bio Signs Registration Rights Agreement With InvestorsAgreement type: Registration Rights Agreement for resale of shares and warrant sharesCounterparty: InvestorsSigned / Effective: Dec 18 2025 / sameDuration / Termination: Until resale or Rule 144 availabilityReason: Provide resale liquidity to private placement investorsAgreement 3: IN8bio Signs Pre-Funded Warrant Agreement With InvestorsAgreement type: Pre-Funded Warrant issuance with immediate exercisability and ownership capCounterparty: InvestorsSigned / Effective: Dec 18 2025 / sameDuration / Termination: Until exercisedReason: Facilitate financing while managing ownership limitsOriginal SEC Filing: IN8BIO, INC. [ INAB ] - 8-K - Dec. 19, 2025DisclaimerThis is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.